Can-Fite Biopharma Ltd Sponsore - stock earnings
CANF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | 196000 USD |
| 2023Q2 | -1.7 million USD | 196000 USD |
| 2023Q1 | -2.4 million USD | 196000 USD |
| 2022Q4 | -3.0 million USD | 197000 USD |
| 2022Q3 | -2.4 million USD | 204000 USD |
| 2022Q2 | -2.4 million USD | 204000 USD |
| 2022Q1 | -2.5 million USD | 205000 USD |
| 2021Q4 | -4.1 million USD | 204000 USD |
| 2021Q3 | -3.4 million USD | 251000 USD |
| 2021Q2 | -3.2 million USD | 250000 USD |
| 2021Q1 | -1.9 million USD | 148000 USD |
| 2020Q4 | -3.6 million USD | 150000 USD |
| 2020Q3 | -2.6 million USD | 211000 USD |
| 2020Q2 | -3.9 million USD | 204000 USD |
| 2020Q1 | -4.3 million USD | 198000 USD |
| 2019Q4 | -1.7 million USD | 192000 USD |
| 2019Q3 | -2.9 million USD | 1.2 million USD |
| 2019Q2 | -3.1 million USD | 389000 USD |
| 2019Q1 | -1.8 million USD | 299000 USD |
| 2018Q4 | -3.4 million USD | 289000 USD |
| 2018Q3 | -177000 USD | 2.6 million USD |
| 2018Q2 | -1.2 million USD | 270000 USD |
| 2018Q1 | -1.7 million USD | 632000 USD |
| 2017Q4 | -1.1 million USD | 105023 USD |
| 2017Q3 | -501907 USD | 586901 USD |
| 2017Q2 | -2.1 million USD | 79408 USD |
| 2017Q1 | -1.3 million USD | 73413 USD |
| 2016Q4 | -1.8 million USD | -1762 USD |
| 2016Q3 | -2.2 million USD | 60265 USD |
| 2016Q2 | -1.4 million USD | 54392 USD |
| 2016Q1 | -1.5 million USD | 56605 USD |
| 2015Q4 | 270510 USD | 27027 USD |
| 2015Q3 | -3.0 million USD | 65991 USD |
| 2015Q2 | -1.7 million USD | 71698 USD |
| 2015Q1 | -343460 USD | ? USD |
| 2014Q4 | -1.7 million USD | ? USD |
| 2014Q3 | -941601 USD | ? USD |
| 2014Q2 | -1.8 million USD | ? USD |
| 2014Q1 | -1.7 million USD | ? USD |
| 2013Q4 | -3.3 million USD | 1.8 million USD |
| 2013Q3 | -1.4 million USD | ? USD |
| 2013Q2 | -1.6 million USD | ? USD |
| 2013Q1 | -2.0 million USD | ? USD |
| 2012Q4 | -9.3 million USD | ? USD |
| 2012Q3 | 1.6 million USD | ? USD |
| 2012Q2 | -1.2 million USD | ? USD |
| 2012Q1 | -1.0 million USD | ? USD |
| 2011Q4 | -3.3 million USD | 111430 USD |
| 2011Q3 | -898054 USD | 119099 USD |
| 2011Q2 | -1.2 million USD | 130550 USD |
| 2011Q1 | -1.4 million USD | 127355 USD |
| 2010Q4 | -1.2 million USD | 152041 USD |
| 2010Q3 | -969945 USD | 129508 USD |
CANF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.0 million USD | 785000 USD |
| 2022 | -10.2 million USD | 810000 USD |
| 2021 | -12.6 million USD | 853000 USD |
| 2020 | -14.8 million USD | 763000 USD |
| 2019 | -13.1 million USD | 2.0 million USD |
| 2018 | -6.6 million USD | 3.8 million USD |
| 2017 | -5.0 million USD | 844746 USD |
| 2016 | -6.9 million USD | 169500 USD |
| 2015 | -4.8 million USD | 164717 USD |
| 2014 | -6.1 million USD | ? USD |
| 2013 | -8.3 million USD | 1.8 million USD |
| 2012 | -5.6 million USD | ? USD |
| 2011 | -6.7 million USD | 468996 USD |
| 2010 | -3.7 million USD | 745210 USD |
CANF
Price: $1.98
52 week price:
Earnings Per Share: -1.48 USD
P/E Ratio: -1.44
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 29900
Market Capitalization: 14.4 million